The Chemours CompanyCCNYSE
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 6,345 | 6,831 | 6,078 |
| Gross Profit | 1,381 | 1,616 | 1,306 |
| Operating Income | 674 | 786 | -123 |
| Net Income | 608 | 578 | -238 |
| EBITDA | 1,178 | 1,195 | 197 |
| EPS Diluted | 3.60 | 3.65 | -1.60 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 1,451 | 1,102 | 1,203 |
| Total Current Assets | 3,345 | 3,214 | 3,835 |
| Total Assets | 7,550 | 7,640 | 8,251 |
| Total Current Liabilities | 1,858 | 1,891 | 2,486 |
| Total Liabilities | 6,468 | 6,533 | 7,512 |
| Total Equity | 1,081 | 1,107 | 737 |
| Total Debt | 3,987 | 3,880 | 4,299 |
| Net Debt | 2,536 | 2,778 | 3,096 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 814 | 755 | 556 |
| Capital Expenditure | -277 | -307 | -370 |
| Free Cash Flow | 537 | 448 | 186 |
| Stock-Based Comp | 34 | 27 | 19 |
| Net Change in Cash | 446 | -247 | 503 |